The physiology of human glucocorticoid receptor β (hGRβ) and glucocorticoid resistance

Annals of the New York Academy of Sciences

Volumn 1069, Issue , 2006, Pages 1-9

  Lewis Tuffin, Laura J ^a,b   Cidlowski, John A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Asthma; Glucocorticoid receptor beta (GR ); Glucocorticoid resistance; Insensitivity; Leukemia; Nasal polyps; Ulcerative colitis

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR BETA;

ACUTE LYMPHOBLASTIC LEUKEMIA; AMINO TERMINAL SEQUENCE; ASTHMA; CARBOXY TERMINAL SEQUENCE; CONFERENCE PAPER; GENE EXPRESSION REGULATION; HEMATOLOGIC MALIGNANCY; HORMONE RESISTANCE; HORMONE RESPONSE; HUMAN; IMMUNOPATHOLOGY; INFLAMMATORY CELL; LIGAND BINDING; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; T LYMPHOCYTE ACTIVATION; ULCERATIVE COLITIS;

EID: 33745625334     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1351.001     Document Type: Conference Paper

References (57)

1. JOBE, A.H. 2001. Glucocorticoids, inflammation and the perinatal lung. Sem. Neonatol. 6: 331-342.
2. KOENIG, J.I., B. KIRKPATRICK & P. LEE. 2002. Glucocorticoid hormones and early brain development in schizophrenia. Neuropsychopharmacology. 27: 309-318.
3. MATTHEWS, S.G. et al. 2002. Glucocorticoids, hypothalamo-pituitary- adrenal (HPA) development, and life after birth. Endocr. Res. 28: 709-718.
4. CANALIS, E., R.C. PEREIRA & A.M. DELANY. 2002. Effects of glucocorticoids on the skeleton. J. Pediat Endocrinol. Metab. 15: 1341-1345.
5. DALLMAN, M.F. et al. 2000. Bottomed out: metabolic significance of the circadian trough in glucocorticoid concentrations. Int. J. Obes. Rel. Metab. Disord: J. Int. Assoc. Study Obes. 24: S40-S46.
6. JEANRENAUD, B. & F. ROHNER-JEANRENAUD. 2000. CNS-periphery relationships and body weight homeostasis: influence of the glucocorticoid status. Int. J. Obes. Rel. Metab. Disord: J. Int. Assoc. Study Obes. 24: S74-S76.
7. RABER, J. 1998. Detrimental effects of chronic hypothalamic-pituitary- adrenal axis activation: from obesity to memory deficits. Mol. Neurobiol. 18: 1-22.
8. FUCHS, E. et al. 2001. Psychosocial stress, glucocorticoids, and structural alterations in the tree shrew hippocampus. Physiol. Behav. 73: 285-291.
9. MACCARI, S. et al. 2003. Prenatal stress and long-term consequences: implications of glucocorticoid hormones. Neurosci. Biobehav. Rev. 27: 119-127.
10. MARINELLI, M. & P.V. PIAZZA. 2002. Interaction between glucocorticoid hormones, stress and psycho stimulant drugs. Eur. J.Neurosci. 16: 387-394.
11. REUS, V.I. & O.M. WOLKOWITZ. 2001. Antiglucocorticoid drugs in the treatment of depression. Exp. Opin. Invest. Drugs 10: 1789-1796.
12. STECKLER, T., F. HOLSBOER & J.M. REUL. 1999. Glucocorticoids and depression. Best Prac. Res. Clin. Endocrinol. Metab. 13: 597-614.
13. ALMAWI, W.Y., M.M. ABOU JAOUDE & X.C. LI. 2002. Transcriptional and post-transcriptional mechanisms of glucocorticoid antiproliferative effects. Hem. Oncol. 20: 17-32.
14. BARNES, P.J. 1998. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin. Sci. 94: 557-572.
15. NACLERIO, R.M. 1988. The pathophysiology of allergic rhinitis: impact of therapeutic intervention. J. Allergy Clin. Immunol. 82: 927-934.
16. RICCARDI, C., S. BRUSCOLI & G. MIGLIORATI. 2002. Molecular mechanisms of immunomodulatory activity of glucocorticoids. Pharmacol. Res. 45: 361-368.
17. PERRETTI, M. & A. AHLUWALIA. 2000. The microcirculation and inflammation: site of action for glucocorticoids. Microcirculation 7: 147-161.
18. SZEFLER, S.J. 2000. Asthma: the new advances. Advan. Pediat. 47: 273-308.
19. EVANS, R.M. 1988. The steroid and thyroid hormone receptor superfamily. Science 240: 889-895.
20. SCHACKE, H., W.D. DOCKE & K. ASADULLAH. 2002. Mechanisms involved in the side effects of glucocorticoids. Pharm. Therap. 96: 23-43.
21. WHELAN, C.J. 2003. Will non-steroid approaches to the treatment of inflammation replace our need for glucocorticoids? Curr. Opin. Invest. Drugs 4: 536-543.
22. SCHAAF, M.J. & J.A. CIDLOWSKI. 2002. Molecular mechanisms of glucocorticoid action and resistance. J. Steroid Biochem. Mol. Biol. 83: 37-48.
23. KINO, T. et al. 2003. Tissue glucocorticoid resistance/hypersensitivity syndromes. J. Steroid Biochem. Mol. Biol. 85: 457-467.
24. HOLLENBERG, S.M. et al. 1985. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318: 635-641.
25. FRANCKE, U. & B.E. FOELLMER. 1989. The glucocorticoid receptor gene is in 5q31-q32 [erratum appears in Genomics 1989 5(2):388]. Genomics 4: 610-612.
26. THERIAULT, A. et al. 1989. Regional chromosomal assignment of the human glucocorticoid receptor gene to 5q31. Hum. Gen. 83: 289-291.
27. ENCIO, I.J. & S.D. DETERA-WADLEIGH. 1991. The genomic structure of the human glucocorticoid receptor. J. Biol. Chem. 256: 7182-7188.
28. OAKLEY, R.H., M. SAR & J.A. CIDLOWSKI. 1996. The human glucocorticoid receptor beta isoform: expression, biochemical properties, and putative function. J. Biol. Chem. 271: 9550-9559.
29. KUMAR, R. & E.B. THOMPSON. 1999. The structure of the nuclear hormone receptors. Steroids 64: 310-319.
30. GIGUERE, V. et al. 1986. Functional domains of the human glucocorticoid receptor. Cell 46: 645-652.
31. HOLLENBERG, S.M. & R.M. EVANS. 1988. Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell 55: 899-906.
32. DEFRANCO, D.B. 1999. Regulation of steroid receptor subcellular trafficking. Cell Biochem. Biophys. 30: 1-24.
33. JENKINS, B.D., C.B. PULLEN & B.D. DARIMONT. 2001. Novel glucocorticoid receptor coactivator effector mechanisms. Trends Endocrinol. Metab. 12: 122-126.
34. PRATT, W.B. 1993. The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor. J. Biol. Chem. 268: 21455-21458.
35. BLEDSOE, R.K. et al. 2002. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110: 93-105.
36. WEATHERMAN, R.V., R.J. FLETTERICK & T.S. SCANLAN. 1999. Nuclear-receptor ligands and ligand-binding domains. Annu. Rev. Biochem. 68: 559-581.
37. STEINMETZ, A.C.U., J.-P. RENAUD & D. MORAS. 2001. Binding of ligands and activation of transcription by nuclear receptors. Annu. Rev. Biophys. Biomol. Struct. 30: 329-359.
38. YUDT, M.R. et al. 2003. Molecular origins for the dominant negative function of human glucocorticoid receptor beta. Mol. Cell Biol. 23: 4319-4330.
39. OAKLEY, R.H. et al. 1997. Expression and subcellular distribution of the beta-isoform of the human glucocorticoid receptor. Endocrinology 138: 5028-5038.
40. BAMBERGER, C.M. et al. 1995. Glucocorticoid receptor β, a potential endogenous inhibitor of glucocorticoid action in humans. J. Clin. Invest. 95: 2435-2441.
41. OAKLEY, R.H. et al. 1999. The dominant negative activity of the human glucocorticoid receptor beta isoform: specificity and mechanisms of action. J. Biol. Chem. 274: 27857-27866.
42. WEBSTER, J.C. et al. 2001. Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance. Proc. Natl. Acad. Sci. USA. 98: 6865-6870.
43. HAUK, P.J. et al. 2002. Increased glucocorticoid receptor β expression converts mouse hybridoma cells to a corticosteroid-insensitive phenotype. Am. J. Resp. Cell Mol. Biol. 27: 361-367.
44. PUJOLS, L. et al. 2002. Expression of glucocorticoid receptor alpha- and beta-isoforms in human cells and tissues. Am. J. Physiol. Cell Physiol. 283: C1324-C1331.
45. HAMID, Q. et al. 1999. Increased glucocorticoid receptor β in airway cells of glucocorticoid-insensitive asthma. Am. J. Resp. Crit. Care Med. 159: 1600-1604.
46. STRICKLAND, I. et al. 2001. High constitutive glucocorticoid receptor β in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. J. Exp. Med. 193: 585-593.
47. HAMILOS, D.L. et al. 2001. GRβ expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone. J. Allergy Clin. Immunol. 108: 59-68.
48. LEUNG, D.Y.M. et al. 1997. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor β. J. Exp. Med. 186: 1567-1574.
49. CHRISTODOULOPOULOS, P. et al. 2000. Increased number of glucocorticoid receptor-β-expressing cells in the airways in fatal asthma. J. Allergy Clin. Immunol. 106: 479-484.
50. SOUSA, A.R. et al. 2000. Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor β-isoform. J. Allergy Clin. Immunol. 105: 943-950.
51. HONDA, M. et al. 2000. Expression of glucocorticoid receptor β in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology 118: 859-866.
52. ORII, F. et al. 2002. Quantitative analysis for human glucocorticoid receptor α/β mRNA in IBD. Biochem. Biophys. Res. Commun. 296: 1286-1294.
53. ZHANG, H. et al. 2005. Significance of glucocorticoid receptor expression in colonie mucosal cells of patients with ulcerative colitis. World J. Gastroenterol. 11: 1775-1778.
54. SHAHIDI, H. et al. 1999. Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia. Biochem. Biophys. Res. Commun. 254: 559-565.
55. LONGUI, C.A. et al. 2000. Low glucocorticoid receptor alpha/beta ratio in T-cell lymphoblastic leukemia. Horm. Metab. Res. 32: 401-406.
56. PIETERS, R. et al. 1998. Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia: implications for treatment of infants. Leukemia 12: 1344-1348.
57. KOGA, Y. et al. 2005. Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children. Pediat. Blood Cancer 45: 121-127.